Activation of p53 by specific agents in potential cancer therapy

Current Medicinal Chemistry - Anti-Cancer Agents

Volumn 5, Issue 2, 2005, Pages 131-135

  Ho, John W ^a   Song, Jing Zheng ^a   Leung, Yuet Kin ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; p53; Specific agents; Tumor suppressor

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; BLEOMYCIN; BLEOMYCIN A2; BLEOMYCIN B2; CAPECITABINE; CISPLATIN; CYTOKINE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; FLUOROURACIL DERIVATIVE; GLYCYRRHETINIC ACID; GLYCYRRHIZA EXTRACT; HERBACEOUS AGENT; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; NORCANTHARIDIN; PACLITAXEL; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROSTAGLANDIN E2; PROTEIN P53; PROTEINASE INHIBITOR; RNA; RUBITECAN; SELENOMETHIONINE; TAUROURSODEOXYCHOLIC ACID; THYMIDINE PHOSPHORYLASE; UNINDEXED DRUG; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CARCINOGENICITY; CELL GROWTH; DRUG EFFICACY; DRUG POTENCY; DRUG SENSITIVITY; DRUG STRUCTURE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; HUMAN; LUNG METASTASIS; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OVARY CARCINOMA; PROTEIN DEFECT; PROTEIN DEFICIENCY; PROTEIN FUNCTION; REVIEW; RNA TRANSLATION; SIDE EFFECT; SOFT TISSUE SARCOMA; TREATMENT PLANNING; TUMOR SUPPRESSOR GENE; VIRAL GENE DELIVERY SYSTEM; WILD TYPE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; MOLECULAR CONFORMATION; NEOPLASMS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR SUPPRESSOR PROTEIN P53;

EID: 14844327973     PISSN: 15680118     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568011053174819     Document Type: Review

References (60)

1. Shen, Y.; White, E. Adv. In Cancer Res. 2001, 82, 55,
2. Wyllie, A.H. Int. Rev. Cytol. 1980, 68, 251.
3. Lain, S.; Lane, D. Eur. J. Cance. 2003, 39, 1053.
4. Lane, D.P.; Lain, S. Trends Mol. Med. 2002, 8 538.
5. McCormick, F. Nat. Rev. Cancer. 2001, 1, 130.
6. Harvey, M.; McArthur, M.J.; Montgomery, C.A,Jr.; Butel, J.S.; Bradley, A.; Donehower, L.A. Nat. Genet. 1993, 5, 225.
7. Kemp, C.J. Mol. Carcinogensis 1995, 12, 132.
8. Akashi, M.; Koeffler, H.P. Clin. Obstet. Cynecol. 1998, 41, 172.
9. Reichel, M.B.; Ali, R.R.; D'Esposito, F.; Clarke, A.R.; Luthert, P.J.; Bhattacharya, S.S. and Hunt, D.M. Cell Death Differ. 1998, 5, 156.
10. Dansset, J.; Cohen, D.; Oren, M.; Telerman, A. Proc. Natl. Acad. Sci. USA 2000, 97, 5346.
11. Zhao, R.; Gish, K.; Murphy, M.; Yin, Y.; Notterman, D.; Hoffman, W.H.; Tom, E.; Mack, D.H.; Levine, A.J. Genes Dev. 2000 14, 981.
12. Caelles, C.; Helmberg, A.; Karin, M. Nature 1994, 370, 220.
13. Bissonnette, N.; Wasylyk, B.; Hunting, D.J. Biochem. Cell. Biol. 1997, 75, 351.
14. Chen, X.; Ko, L.J.; Jayaraman, L.; Prives, C. Genes Dev. 1996, 10, 2438.
15. Ashcroft, M.; Kubbutat, M.H.; Vousden, K.H. Mol. Cell Biol. 1999, 19, 1751.
16. Lakin, N.D.; Jackson, S.P. Oncogene 1999, 18 7644.
17. Sakaguchi, K.; Saito, S.; Higashimoto, Y.; Roy, S.; Anderson, C.W.; Appella, E. J. Biol. Chem. 2000, 275, 9278.
18. Shieh, S.-Y.; Ahn, J.; Tamai, K.; Taya, Y.; Prives, C. Genes and Dev. 2000, 14, 289.
19. Jayaraman, L.; Prives, C. Cell Mol. Life Sci. 1999 55, 76.
20. Khosravi, R.; Maya, R.; Gottlieb, T.; Oren, M.; Shiloh, Y.; Shkedy D. Proc. Natl. Acad. Sci. USA 1999, 96, 14973.
21. Gostissa, M.; Hengstermann, A.; Fogal, V.; Sandy, P.; Scheffner, M.; DelSal, G. EMBO J. 1999, 18, 6462.
22. Balint, E.; Vousden, K.H. Br. J. Cancer 2001, 85(12), 1813.
23. Shaw, P.; Freeman, J.; Bovey, R.; Iggo, R. Oncogene 1996, 12, 921.
24. Wang, X.; Ohnishi, K.; Takahashi, A.; Ohnishi, T. Oncogene 1998, 17, 2819.
25. Vaziri, H.; West, M.D.; Allsopp, R.C.; Davison, T.S.; Wu, Y.-S.; Arrowsmith, C.H.; Poirier, G.G.; Benchimol, S. EMBO J. 1997, 16, 6018.
26. Lundberg, A.S.; Hahn, W.C.; Gupta, P.; Weinberg, R.A. Curr. Opin. Cell Biol. 2000, 12, 705.
27. Brugarolas, J.; Chandrasekaran, C.; Gordon, J.L.; Beach, D.; Jacks, T.; Hannon, G.J. Nature 1995, 377, 552.
28. Bates, S.; Ryan, K.M.; Phillips, A.C.; Vousden, K.H. Oncogene 1998, 17, 1691.
29. Wang, X.W.; Zhan, Q; Coursen, J.D.; Khan, M.A.; Kontry, H.U.; Yu, L.; Hollander, M.C.; O'Connor, P.M.; Fornace, A.J.J.; Harris, C.C. Proc. Natl. Acad. Sci. USA 1999, 96, 3706.
30. Ohki, R.; Nemoto, J.; Mrasawa, H.; Oda, E.; Inazawa, J.; Tanaka, N.; Taniguchi, T. J. Biol. Chem. 2000, 275, 22627.
31. Vousden, K,H. Cell 2000, 101, 691.
32. Miyashita, T., Reed, J.C. Cell 1995, 80, 293.
33. Oda, K.; Arakawa, H.; Tanaka, T.; Matsuda, K.; Tanikawa, C.; Mori, T.; Nishimori, H.; Tamai, K.; Tokino, T.; Nakamura, Y.; Taya, Y. Cell 2000, 102, 849.
34. Bossy-Wetzel, E.; Green, D.R. Mutat. Res. 1999, 434, 243.
35. Polyak, K.; Xia, Y.; Zweier, J.L.; Kinzler, K.W.; Vogelstein, B. Nature 1997, 389, 300.
36. Owen-Schaub, L.B.; Zhang, W.; Cusack, J.C.; Angelo, L.S.; Santee, S.M.; Fujiwara, T.; Roth, J.A.; Deisseroth, A.B.; Zhang, W.-W.; Kruzel, E.; Radinsky, R. Mol. Cell Biol. 1995, 15, 3032.
37. Takimoto, R.; El-Deivy, W.S. Oncogene 2000, 19 1735.
38. Ashkenazi, A.; Dixit, V.M. Science 1998, 281 1305.
39. Prisco, M.; Hongo, A.; Rizzo, M.G.; Sacchi, A.; Baserga, R. Mol. Cell Biol. 1997, 17, 1084.
40. Ryan, K.M.; Ernst, M.K.; Rice, N.R.; Vousden, K.H. Nature 2000, 404, 892.
41. Chen, X.; Ko, L.J.; Jayaraman, L.; Prives, C. Gene and Dev. 1996, 10, 2438.
42. Wani, M.A.; Zhu, Q.Z.; El-Mahdy, M.; Wani, A.A. Carcinogenesis 1999, 20, 765.
43. Ashcraft, M.; Kubbutat, M.H.; Vousden, K.H. Mol. Cell Biol. 1999, 19, 1751.
44. Toi, M.; Bando, H.; Horiguchi, S.; Takada, M.; Kataoka, A.; Ueno, T.; Saji, S.; Muta, M.; Funata, N.; Ohno, S. Br. J. Cancer 2004, 90(12), 2338.
45. Marchal, J.A.; Boulaiz, H.; Suarez, I.; Saniger, E.; Campos, J.; Carrilo, E.; Prados, J.; Gallo, M.A.; Espinosa, A.; Aranega, A. Invest. New Drugs 2004, 22(4), 379.
46. Lavarino, C.; Pilotti, S.; Oggionni, M.; Gatti, L.; Perego, P.; Bresciani, G.; Pierotti, M.A.; Scambia, G.; Ferrandina, G.; Fagotti, A.; Mangioni, C.; Lucchini, V.; Vecchione, F.; Bolis, G.; Scarfone, G.; Zunino, F. J. Clin. Oncology 2000, 18(23), 3936.
47. Song, K.; Cowan, K.H.; Sinha, B.K. Oncology Res. 1999, 11(3), 153.
48. Yeh, P.Y.; Chuang, S.E.; Yeh, K.H.; Song, Y.C.; Chang, L.L.Y.; Cheng, A.L. Oncogene 2004, 23(20), 3580.
49. Tergaonkar, V.; Pando, M.; Vafa, O.; Wahl, G.; Verma, I. Cancer Cell 2002, 1(5), 493.
50. Gautam, A.; Waldrep, J.C.; Densmore, C.L.; Koshkina, N.; Melton, S.; Roberts, L.; Gilbert, B.; Knight, V. Gene Therapy 2002, 9(5), 353.
51. Smith, M.L.; Lancia, J.K.; Mercer, T.T.; Ip, C. Anticancer Res. 2004, 24, 1401.
52. Ramalho, R.M.; Ribeiro, P.S.; Sola, S.; Castro, R.E.; Steer, C.J.; Rodrigues, C.M.P. J. Neurochem. 2004, 90(3), 567.
53. Pearson, M.; Carbone, R.; Sebastiani, C.; Cioce, M.; Fagioli, M.; Saito, S.; Higashimoto, Y.; Appella, E.; Minucci, S.; Pandolfi, P.P.; Pelicci, P.G. Nature 2000, 406, 207.
54. Hong, C.Y.; Huang, S.C.; Lin, S.K.; Lee, J.J.; Chueh, L.L.; Lee, C.H.K.; Lin, J.H.; Hsiao, M. Biochem. Biophy. Res. Commun. 2000, 276(1), 278.
55. Leung, Y.K.; Ng, T.B., Ho, J.W. Life Sci. 2003, 73, 3109.
56. Chan, H.T.; Chan, C.; Ho, J.W. Toxicology 2003, 188, 211.
57. Lotem, J.; Sachs, L. Proc. Natl. Acad. Sci. USA 1997 94(17), 9349.
58. Bokemeyer, C.; Ludwig, E.; Reile, D.; Harstrick, A.; Poliwoda, H.; Schmoll, H.J. Oncology Reports 1995, 2, 161.
59. Kawada, M.; Yoshimoto, Y.; Minamiguchi, K.; Kumagai, H.; Someno, T.; Masuda, T.; Ishizuka, M.; Ikeda, D. Anticancer Res. 2004, 24, 1561.
60. Mallmann, P.; Bruehl, P. Infection 1992, 20 S67.